KYMR
Kymera Therapeutics, Inc. · Healthcare
Director Bruce Booth sold $3.8M of Kymera Therapeutics, Inc.
Sold$3,821,739
$30.22Price
126,474Shares
−12%Stake
What KYMR did after the filing
- The stock from Tue, Jan 17 open, $35.00
- −8.4%
- S&P 500, same days
- −0.9%
Measured over 30 trading days, to the Mar 1 close.
Traded Wed, Jan 11. Filed Fri, Jan 13, 4:53 PM ET, after the close. Returns use the Jan 17 open and the Mar 1 close. Not investment advice.